Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine vs Midazolam for Post-HTO Analgesia
NCT06082232Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and midazolam in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Time to first analgesic request at 24 hours. Status: unknown.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06082232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06082232.